Neurosoft Bioelectronics

Neurosoft Bioelectronics is pioneering the development of soft implantable brain computer interfaces with the slogan "Soft implantable brain computer interfaces". The company was founded in 2019 and is headquartered in Switzerland. Their focus on the Health Care industry aligns with their mission to enhance patient care for individuals suffering from neurological disorders. At the core of their innovation is the creation of soft implantable electrodes designed to interface with the nervous system. The unique technology developed by Neurosoft Bioelectronics enables the production of highly compliant neural interfaces, allowing for long-term bio-integration within the body. This breakthrough opens up new therapeutic possibilities, ultimately improving patient outcomes. Their latest milestone, a grant investment received on 28 April 2023 from Innosuisse, signifies a strong validation of their groundbreaking work. Neurosoft Bioelectronics is poised to make significant contributions in the field of neurological treatment with their innovative approach to neural interfaces.